Lymphoid Tissue and Plasmacytoid Dendritic Cells and Macrophages Do Not Share a Common Macrophage-Dendritic Cell-Restricted Progenitor  by Sathe, Priyanka et al.
Immunity
ArticleLymphoid Tissue and Plasmacytoid Dendritic Cells
and Macrophages Do Not Share a Common
Macrophage-Dendritic Cell-Restricted Progenitor
Priyanka Sathe,1,2,* Donald Metcalf,1,2 David Vremec,1,2 Shalin H. Naik,1,2,3 Wallace Y. Langdon,4
Nicholas D. Huntington,1,2 Li Wu,5 and Ken Shortman1,2,6,*
1The Walter and Eliza Hall Institute, Parkville, VIC 3050, Australia
2Department of Medical Biology, The University of Melbourne, VIC 3010, Australia
3The Netherlands Cancer Institute, 1066CX Amsterdam, the Netherlands
4School of Pathology and Laboratory Medicine, University of Western Australia, WA 6009, Australia
5Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University School of Medicine, Beijing 100084, China
6Burnet Institute, Melbourne, VIC 3010, Australia
*Correspondence: sathe@wehi.edu.au (P.S.), shortman@wehi.edu.au (K.S.)
http://dx.doi.org/10.1016/j.immuni.2014.05.020SUMMARY
The relationship between dendritic cells (DCs) and
macrophages is often debated. Here we ask whether
steady-state, lymphoid-tissue-resident conventional
DCs (cDCs), plasmacytoid DCs (pDCs), and macro-
phages share a common macrophage-DC-restricted
precursor (MDP). Using new clonal culture assays
combined with adoptive transfer, we found that
MDP fractions isolated by previous strategies are
dominated by precursors of macrophages and
monocytes, include some multipotent precursors of
other hematopoietic lineages, but contain few pre-
cursors of resident cDCs and pDCs and no detect-
able common precursors restricted to these DC
types andmacrophages. Overall we find no evidence
for a common restrictedMDP leading to both macro-
phages and FL-dependent, resident cDCs and pDCs.
INTRODUCTION
Mapping the developmental pathway of the antigen-presenting
dendritic cells (DCs) is complicated by the existence of multiple
DC subtypes with specialized functions (Shortman and Liu,
2002). The steady-state DC network includes both plasmacytoid
DCs (pDCs) and conventional DCs (cDCs). Here, we focus on
lymphoid-tissue-resident cDCs (resident cDCs), which can be
subdivided in mice into CD8a+Clec9A+ and CD8aClec9A
cDCs; CD8+ cDCs express lower amounts of CD11b than
CD8 cDCs (Vremec et al., 1992, 2000). Close equivalents of
these subsets have been identified in humans (Bachem et al.,
2010; Crozat et al., 2010; Jongbloed et al., 2010; Mittag et al.,
2011; Poulin et al., 2010). Of particular interest is their
developmental relationship with fellow mononuclear phago-
cytes, macrophages.
It is now clear that many macrophages are of embryonic origin
(Hashimoto et al., 2013; Schulz et al., 2012), but the relationship
between bone marrow (BM)-derived macrophages and DCs re-104 Immunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc.mains unclear. A late precursor, monocytes, can produce ‘‘in-
flammatory’’ and some migratory DCs (Ginhoux et al., 2009;
Varol et al., 2007), but not steady-state resident DCs (Naik
et al., 2006, 2007; Serbina et al., 2003). Steady-state resident
DC and macrophage developmental potential coexists in com-
mon myeloid progenitors (CMPs) (Akashi et al., 2000; D’Amico
and Wu, 2003; Karsunky et al., 2003; Manz et al., 2001). Further
downstream, the common DC progenitors (CDPs) of resident
cDCs and pDCs have lost most macrophage potential (Naik
et al., 2007; Onai et al., 2007). Subsequent work has described
more restricted downstream pDC (Onai et al., 2013; Sathe
et al., 2013) and monocyte (Hettinger et al., 2013) progenitors.
Thus the developmental pathways leading either to resident
cDCs and pDCs or to macrophages diverge between the CMP
and CDP stages.
A favored hypothesis is that CMPs develop into macrophage-
and DC-restricted progenitors (MDPs), retaining resident cDC,
pDC, and macrophage, but not granulocyte, potential. This
was proposed after the isolation of a BM fraction with develop-
mental potential restricted to macrophages and DCs (Fogg
et al., 2006). Clear clonal evidence was presented that individual
MDPs could produce both macrophages and DCs, but at that
time there were no markers allowing distinction in culture be-
tween the resident cDCs and inflammatory or monocyte-derived
DCs. The evidence for resident cDC production from this MDP
fraction came from nonclonal adoptive transfer into irradiated re-
cipients, when CD8+ DCs, and in later reports, pDCs (Auffray
et al., 2009; Waskow et al., 2008) and migratory DCs (Bogunovic
et al., 2009; del Rio et al., 2008; Ginhoux et al., 2009), were
produced.
Here we describe the developmental potential of macrophage
and DC precursor populations isolated from BM using adoptive
transfer, clonal agar colony assays, and clonal and limit dilution
liquid culture assays. The MDP population, isolated via the
approaches of previous studies, retained a capacity to form, in
addition tomacrophages and DCs, other hematopoietic lineages
on adoptive transfer. However, by limit dilution and clonal culture
assays, we found the MDP fraction to contain many precursors
of macrophages, few precursors of resident cDCs or pDCs,
and very few common precursors of macrophages, resident
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tions, we found no evidence for a discrete macrophage-DC-
restricted precursor as a major intermediate on the pathway to
resident cDCs and pDCs.
RESULTS
Developmental Potential of MDP Fractions on Adoptive
Transfer
We first reassessed the adoptive transfer evidence for a BM pre-
cursor restricted to macrophage, resident cDC, and pDC devel-
opment. A confounding factor is the variety of markers that have
been used to isolate MDPs. MDPs were originally isolated as
lineage(lin)c-kithisca-1CX3CR1
+, and shown to be CD16/
32hi; the high expression of CX3CR1 distinguished them from
granulocyte-macrophage precursors (GMPs) (Fogg et al.,
2006). Such MDPs also stained positive for macrophage col-
ony-stimulating factor receptor (M-CSFR) (Figure S1 available
online). Subsequently MDPs were isolated in a much broader
definition as lin M-CSFR+ (Waskow et al., 2008). Such MDPs
should include GMPs because we find that the majority of
GMPs express the M-CSFR (Figure S1). In agreement with
others (Fogg et al., 2006), we find the population described as
linc-kithiCD16/32hiCX3CR1
+ was lower for expression of c-kit
(CD117) than its CX3CR1
 counterpart (Figure 1). Thus, the
descriptions of MDPs as c-kitint or c-kithi refer to equivalent pop-
ulations, which we here denote as c-kithi. We therefore focused
on two distinct procedures for segregating putative MDPs: as
linc-kithisca-1CD16/32hiCX3CR1
+ (referred to as CX3CR1
+
MDPs) or linM-CSFR+ (referred to as M-CSFR+ MDPs) (Fig-
ure 1). Lin BM was obtained by depleting BM cells expressing
CD2, CD3, CD8, CD19, CD45R, CD11b, TER119, or Ly6G;
such depletion resulted in 99% lin cells (Figure 1). The purity
of sorted populations was determined by reanalysis. Impor-
tantly, the CX3CR1
+ MDP population contained very low
amounts of contamination with CMPs (0.1%–0.7%) or linsca-
1+c-kit+ (LSK) cells (0.1%–0.3%) but showed a little overlap
with GMPs (2.0%–11.1%) (Figure S1).
These MDP populations were sorted from CD45.1 mice and
injected into lethally irradiated congenic recipients. BM and
spleens of the recipients were analyzed 1 and 2 weeks after
transfer, gating donor-derived cells as CD45.1+CD45.2 (Fig-
ure 1D). In agreement with previous publications, both popula-
tions gave rise to macrophages and monocytes, pDCs, and
CD8+ and CD8 spleen-resident DCs (Figures 1E and 1F).
CX3CR1
+ MDPs efficiently generated Ly6G+ granulocytes (Fig-
ure 1E), but not B, T, or NK cells (data not shown). M-CSFR+
MDPs also gave rise to Ly6G+ granulocytes, as well B cells
and NK cells (Figure 1F). The distribution of cell types produced
varied slightly between the different MDP fractions (Figure 1G).
The Ly6G+ progeny of the transferred populations showed a
granulocytic morphology (Figure 1H). Thus, neither population
defined as MDPs was restricted to the macrophage and den-
dritic cell lineages.
Developmental Potential of MDPs in Clonal Agar Colony
Assays
The finding that these MDP populations retained a potential to
develop into other hematopoietic lineages could indicate thatthe cells producing macrophages and DCs were not restricted
to these lineages. Alternatively, it may have been a result of inclu-
sion of other precursors alongside true MDPs. It was important
to check this at a clonal level. CX3CR1
+ MDPs and CMPs were
cultured in soft agar with a variety of cytokines and their potential
to expand sufficiently to produce various types of myeloid col-
onies was determined. This assay did not allow determination
of DC developmental potential but did allow a determination of
the relative frequency of granulocyte versus macrophage pre-
cursors with sufficient expansion potential to form visible col-
onies. We could therefore assess whether granulocyte and
macrophage colony potential existed in distinct, or the same,
precursor cells.
MDPs gave rise to colonies of macrophages alone, of granulo-
cytes alone, and importantly colonies containing both macro-
phages and granulocytes (Table 1). The frequency of granulocyte
colony progenitors within MDPs was lower than the frequency of
granulocyte colony progenitors within CMPs; nevertheless, a
substantial proportion of MDP-derived colonies contained gran-
ulocytes. The proportion of granulocyte colonyprecursors (20%–
40% of all colonies produced, depending on the stimulus) was
higher than could be accounted for by the possible 2%–11%
overlap of a true MDP with GMPs, assuming both contained
similar proportions of precursors with the expansion potential
to form colonies. Importantly, the potential of the MDP fraction
to form megakaryocyte colonies when cultured with stem cell
factor (SCF), interleukin-3 (IL-3), and erythropoietin (EPO) was 1
per 10,000 cells, approximately 0.5% of a similar capacity in
CMPs, excluding significant contamination with upstream pre-
cursors such as CMPs or LSK cells. Thus, the granulocyte
progenitor activity within MDPs could not be attributed to
contaminating precursors, but rather was a feature of MDPs.
CX3CR1
– Granulocyte Development from CX3CR1
+
Progenitors
One reason for supposingCX3CR1
+MDPs should not give rise to
granulocytes was that granulocytes are CX3CR1
. Accordingly,
we examined the granulocytes that developed from CX3CR1
+
MDPs on adoptive transfer. They showed only marginal GFP
fluorescence, similar to splenic granulocytes (Figure S1D; Jung
et al., 2000). We then examined in detail CX3CR1
+MDP develop-
ment into granulocytes by culturing MDPs with GM-CSF. Over
5 days of culture, Ly6G+ granulocytes developed along with a
larger number of CD11bhiF4/80+ macrophages (Figure S1E).
This was accompanied by a progressive loss of GFP fluores-
cence in the granulocytes (Figure S1F). Thus, both in vitro and
in vivo results indicated that CX3CR1
 granulocytes could arise
from CX3CR1
+ MDPs.
Cytokine Requirements for Development of DC
Precursors in BM
Despite the role of FL as the limiting cytokine for resident DC and
pDC production (D’Amico and Wu, 2003; Karsunky et al., 2003;
Manz et al., 2001; McKenna et al., 2000; Onai et al., 2006), it was
thought FL had its main effect on the mobilization of DC precur-
sors out of BM and the terminal expansion of DCs in the
lymphoid organs, with little effect on the development of DC pre-
cursors in BM (Waskow et al., 2008). This conclusion was based
on the enumeration of linM-CSFR+ MDPs in Flt3/ BM. In lightImmunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc. 105
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Figure 1. Isolation of MDPs and Identification of Progeny on Transfer
(A) Plot is representative of more than ten experiments.
(B) CX3CR1
+ MDPs were isolated from CD45.1 CX3CR1-GFP BM as lin
CX3CR1
+c-kithiCD16/32hi. Plot is representative of three experiments.
(C) M-CSFR+ MDPs were isolated from CD45.1 BM as linM-CSFR+. Plot is representative of six experiments.
MDPs were transferred into CD45.2 lethally irradiated recipients and recipient spleens analyzed 7 days after transfer.
(legend continued on next page)
Immunity
Reconsideration of MDP as a Stage in DC Development
106 Immunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc.
Table 1. Agar Colony Assays of the Frequency of Myeloid Progenitors within the MDP Population
Stimulus
MDP CMP
Total Colonies
(per 103 Progenitors)
Colony Type (% of Total) Total Colonies
(per 103 Progenitors)
Colony Type (% of Total)
G G + M M G G + M M
GM-CSF 128 ± 21 11 ± 3 9 ± 2 74 ± 3 82 ± 32 36 ± 18 11 ± 3 43 ± 12
M-CSF 90 ± 36 2 ± 1 2 ± 1 94 ± 2 97 ± 44 6 ± 1 7 ± 4 87 ± 4
SCF+IL-3+EPO 182 ± 103 35 ± 7 6 ± 5 55 ± 8 52 ± 29 49 ± 6 15 ± 2 25 ± 8
Linc-kithiCX3CR1
+CD16/32hi cells (MDP) or linc-kithisca-1CD34hiCD16/32lo cells (CMP) were cultured in semisolid agar with indicated cytokines for
7 days. The frequency of progenitors giving rise to colonies containing macrophages (M), granulocytes (G), or granulocytes and macrophages (G+M)
per 103 cells is shown. The mean ± standard error of two (CMP) or three (MDP) experiments is shown. The incidence of megakaryocyte colonies, seen
only in the SCF + IL-3 + EPO cultures, was 20 per 103 cells for CMPs and 0.1 per 103 cells for MDPs.
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for other lineages, we re-examined the effect of FL deficiency by
focusing on CDP, a key precursor on the pathway to resident
DCs and pDCs (Naik et al., 2007; Onai et al., 2007), rather than
the previously examined linM-CSFR+ MDPs (Figure S2). We
found in FL-deficient BM a 50% drop in lin BM and a similar
50% drop in MDPs, consistent with the role of FL in expansion
of early progenitors. In contrast, CDP numbers were reduced
to 12.5% of WT levels, indicating a specific defect in CDP devel-
opment. In agreement with another study (Kingston et al., 2009),
we conclude that FL, in addition to promoting the final expansion
of DCs in the periphery, promotes production of DC precursors
in BM.
Effect of GM-CSF on the Development of Different DC
Types
Different cytokines promote the development of different DC
types in culture: GM-CSF promotes development of DCs from
monocytes (Sallusto and Lanzavecchia, 1994; Zhan et al.,
2012) whereas FL drives development of pDCs and the equiva-
lent of spleen-resident CD8+ and CD8 cDCs, although cul-
ture-derived DCs do not express CD8 (Naik et al., 2005; Sathe
et al., 2011). The original study showing clonal development in
culture of both macrophages and DCs from MDPs used GM-
CSF either alone or with FL (Fogg et al., 2006), so might have
been supposed to allow all DC types to develop. We reassessed
the influence of GM-CSF at the levels used on the development
of DCs in culture, comparing MDPs with whole BM and using
newer markers for DC subtypes (Naik et al., 2005; Sathe et al.,
2011). After culture for 8 days, DCs were gated as CD11c+,
pDCs distinguished as CD45RA+, and the culture equivalents
of CD8+ cDCs distinguished as Clec9A+. Resident CD8 cDCs
and the monocyte-derived type of DCs are both Clec9A
CD45RA so they are not distinguished by these markers.(D) Donor-derived cells were identified as CD45.1+CD45.2 and analyzed for the p
CD8+ and CD8 DCs, and CD11c+BST-2+ pDCs, as well as for CD19+ B cells, C
(E) Progeny of MDPs isolated as in (A). Results are representative of two experim
(F) Progeny of MDPs isolated as in (B). Results are representative of four experim
Note that the reagents used to analyze MDP progeny differed in the experiments r
each cell type was defined based on the staining of populations derived from the
were detected at 14 days after transfer, although the proportions differed. Where
change in the axis scale.
(G) The proportion of MDP progeny that gave rise to each cell type shown in (E) an
standard error.
(H) Ly6G+ cells derived from CX3CR1
+ MDPs were sorted and stained with May-Although the level of CD11b increases on many DC types in cul-
ture, a very high expression is characteristic of DCs of the type
derived from monocytes.
Culture of BM cells with FL produced CD11c+ DCs including
Clec9A+ cDCs and CD45RA+ pDCs (Figure 2) as expected
(Naik et al., 2005; Sathe et al., 2011); these derived from the
outgrowth of a low incidence of DC precursors (Naik et al.,
2007). Culture of MDPs with FL alone produced very few pDCs
but did produce a moderate yield of Clec9A+CD8+ cDC equiva-
lents in agreement with adoptive transfer results. Addition of
GM-CSF to FL in the BM cultures largely suppressed or
swamped the production of pDCs and the CD8+ cDC equiva-
lents, leaving only CD11bhi DCs as the dominant product. This
effect was particularly strikingwithMDPs, where a very high yield
of CD11bhi DCs was obtained without evidence of CD45RA+
pDCs or of Clec9A+CD8+ cDC equivalents. In the presence of
GM-CSF, the level of CD11b on the DCs produced was espe-
cially high, typical of monocyte-derived DCs. Deflection of DC
development away from the resident cDCs and pDCs by GM-
CSF has also been reported by others (Zhan et al., 2011). We
conclude that the original clonal data obtained from cultures of
MDPs with GM-CSF probably reflected precursors making
macrophages and the monocyte-derived DC type, rather than
making resident cDCs and pDCs.
Estimating the Frequency of Macrophage and DC
Progenitors
Although in our hands MDPs were not restricted to the macro-
phage and DC lineages, this did not rule out the presence of
true macrophage-DC-committed precursors. To develop a cul-
ture assay for precursors of resident cDCs and pDCs, or of mac-
rophages, we cultured BM fractions with FL and M-CSF, the
instructive cytokines for development of DCs andmacrophages,
respectively. To seek common DC-macrophage precursors, weresence of CD11bhiF4/80+ macrophages, CD11bhiF4/80monocytes, CD11c+
D49b+ NK cells, and Ly6G+ granulocytes.
ents.
ents.
epresented in (E) from those represented in (F). In both (E) and (F), the gating of
CD45.1CD45.2+ BM cotransferred with MDPs. In all cases, the same progeny
appropriate, data are shown on a biexponential display. A faint line indicates a
d (F). Data are pooled from two to four experiments and expressed as mean ±
Grunwald Giemsa.
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Figure 2. Effect of Cytokine Combinations on the Type of DCs Generated in Culture
MDPs (CX3CR1
+c-kithiCD16/32hi) were isolated from CX3CR1-GFP BM. MDPs or BM cells were cultured with FL or FL plus GM-CSF. MDP cultures were diluted
15-fold with fresh medium and cytokines at day 4. At day 8, progeny cells were counted and stained, and DCs were gated as CD11c+ and analyzed for markers
distinguishing different DC types. Total viable cell yield from 106 cells cultured is shown. Results are representative of three experiments.
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maximal yield of all these products together. On analysis macro-
phages were first identified as CD11bhiF4/80+. They were then
gated out to avoid interference from their autofluorescence
and low CD11c expression, the remaining CD11c+ cells then
being identified as DCs. In all cases BM filler cells from congenic
mice were used. Importantly, these BM fillers in all cultures pro-
duced resident cDCs and pDCs, indicating that conditions were
suitable for their development if appropriate precursors were
present. An estimate of the frequency of DC and macrophage
precursors was then obtained by a limit dilution approach
(Table 2, Figure S3). In these experiments MDPs were isolated
as linc-kithisca-1CX3CR1
+, without gating on CD16/32108 Immunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc.expression, following the isolation protocol used in the original
study (Fogg et al., 2006).
In response to FL or M-CSF, the frequency of DC progenitors
or macrophage progenitors within the uncommitted LSK fraction
was 48% or 20%, respectively (Table 2). Thus as few as five LSK
cells could give rise to both DCs and macrophages, indicating a
high frequency of either common or separate macrophage and
DC progenitors. The frequency of DC and macrophage progen-
itors was similarly high in CMPs, with 18 CMPs sufficient to give
rise to both macrophages and DCs. However, under no condi-
tions tested were any resident cDC or pDC progeny observed
from fewer than 53 103 MDPs, indicating a maximal DC precur-
sor frequency of 0.02%. In contrast, as few as sevenMDPs were
Table 2. Limit Dilution Analysis of Macrophage and DC Potential within BM Precursor Populations
Precursor Frequency (% of Population)
FL FL + M-CSF M-CSF
DC Mac DC Mac DC Mac
LSK 18.7 (9.9–35.5) 9.4 (4.8–17.9) 47.8 (25.0–91.7) 19.6 (10.3–37.2) 58.9 (27.2–100) 0.5 (0.2–1.1)
CMP 20.0 (10.6–38.1) 4.6 (2.4–8.7) 8.8 (4.2–18.4) 4.6 (2.2–9.6) 7.5 (4.1–14.6) 5.6 (3.0–10.6)
MDP 0.01 (0.007–0.03) 1.3 (0.6–2.4) 0.02 (0.01–0.06) 6.4 (2.7–15.3) 0.004 (0.001–0.01) 14.3 (5.7–36.4)
Lin BM (excluding
above progenitors)
0.10 (0.06–0.2) 0.15 (0.08–0.3) 0.12 (0.06–0.2) 0.19 (0.09–0.4) <0.002 <0.002
LSK cells, CMPs (linc-kithisca-1CD34+CD16/32lo), MDPs (linCX3CR1
+c-kithisca-1), and all remaining lin cells were isolated from CD45.1
CX3CR1-GFP BM and cultured for 7 days at a range of cell concentrations (1–5 3 10
5 cells/well) with the indicated cytokines and 0.3 3 106
CD45.2 BM filler cells. Cultures were analyzed at day 7 for the presence of CD11bhiF4/80+ macrophages/monocytes and CD11c+ DCs and wells
that did not contain macrophages or DCs deemed ‘‘nonresponders.’’ Precursor frequency was estimated using ELDA software (Hu and Smyth,
2009). Estimated frequency as a percentage of the population with a 95% confidence interval from data collated from three experiments is shown.
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(Table 2). Hence MDPs appeared to include many macro-
phage-biased progenitors but only rare progenitors with resident
cDC or pDC potential. Thus the incidence of possible common
macrophage-DC precursors in the MDP fraction was very low.
We also examined a lin BM fraction that excluded LSK cells,
CMPs, and MDPs; this fraction gave rise to both macrophages
and DCs if 1,000 or more cells were cultured. This suggested
that if a common restricted progenitor for macrophages and
DCs existed, it would be present at low frequency within this pro-
genitor-depleted BM fraction, rather than within the originally
described MDPs.
A Clonal Assay for Generation of Macrophages and DCs
by MDPs
These limit dilution assays could determine whether macro-
phage and DC precursors were present within a population but
not whether the product cells arose from the same precursor.
To test whether single MDPs could give rise to macrophages,
resident cDCs, and pDCs, we devised a new clonal assay based
on our previous assay for DC production (Naik et al., 2007) but
using both FL and M-CSF as in the cultures above. In this assay,
putative precursors were isolated from BM of mice expressing
GFP from the ubiquitin C promoter (UBC-GFP mice). Single
GFP+ cells were cultured with nonfluorescent filler cells, so the
progeny of single progenitors could be identified as GFP+ (Fig-
ure 3A). Cultures containing fluorescent progeny were stained
to identify macrophages, resident type cDCs, and pDCs. To vali-
date the ability to detect macrophage and DC progenitors, we
cultured single cells from the LSK fraction enriched for hemato-
poietic stem cells and early multipotent progenitors. We could
clearly detect both macrophages and DCs in the progeny of sin-
gle LSK cells (Figure 3B, Table 3). Importantly, the DC progeny
included pDCs and CD11blo and CD11bhi cDCs. Although 85%
of the clones from LSK cells contained both macrophages and
DCs (Table 3), some LSK cells gave rise to small clones contain-
ing only macrophages (Figure 3C) or only DCs (Figure 3D).
We now had an assay capable of determining whether a single
precursor cell had the potential to form macrophages, pDCs,
and steady-state cDCs, rather than macrophages and mono-
cyte-derivedDCs.We then used this assay to search for bipotent
macrophage-DC precursors within MDPs. MDPs, as previouslydescribed (Fogg et al., 2006), are M-CSFR+CD16/32hi. Initially,
to allow use of UBC-GFP BM, we analyzed single cells from
the linM-CSFR+CD16/32hi fraction (Figure 3E), reasoning that
if bipotent progenitors existed within the MDP population, we
should detect them within this MDP-enriched population. How-
ever, in contrast to LSK cells, of the 14 clones analyzed, none
contained DCs (Table 3) but rather were restricted to macro-
phage production (Figure 3F). Importantly, we could detect
macrophages, pDCs, CD11blo, and CD11bhi cDCs among the
progeny of the BM filler cells (Figure 3G), indicating that the cul-
ture conditions allowed production of these lineages if the
appropriate precursors were present.
As a final check, in two experiments we applied the single-cell
clonal assay to exactly the same linc-kithisca-1CX3CR1
+ MDP
fraction as in the original study (Fogg et al., 2006). In this case, we
isolated MDPs or LSK cells from CD45.1+CX3CR1-GFP BM, and
therefore the UBC-GFP mice could not be used. Single MDPs
or LSK cells were cultured with CD45.2 BM fillers, and
clones arising from the single progenitors were identified as
CD45.1+CD45.2 cells (Figure S4A) after staining and analysis
of all culture wells. Only wells containing more than ten CD45.1+
CD45.2 cells were included in the analysis. Of the 61 MDP-
derived clones detected by this approach, 58 solely produced
macrophages (Table 3; Figure S4B). Only three clones
produced DCs; one produced DCs only (Figure S4C) and two
producedDCs together withmacrophages (Table 3; Figure S4D).
Only one of the latter showed evidence of CD11blo cDCs and
possible BST-2+ pDCs (Figure S4D). Importantly, of the LSK-
derived clones used as a positive control, 80% contained both
macrophage and DC progeny in an average ratio of 1 to 3.
Further, the filler cells in all wells contained both DC and macro-
phage progeny (Figure S4E), indicating that the conditions were
appropriate for generation of both lineages. This confirmed the
conclusions from limit dilution assays and from the clonal assay
using UBC-GFP BM that the MDP fraction included many
macrophage precursors but very few common precursors of
macrophages, resident DCs, and pDCs.
A Search for Macrophage-DC Precursors in Other BM
Fractions
Although we had not detected any significant level of bipotent
macrophage and DC progenitors within MDPs, such progenitorsImmunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc. 109
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Figure 3. A Clonal Assay for Macrophage-DC Potential
(A–D) LSK cells (linc-kithisca-1+) were isolated from UBC-GFP BM and sorted single cells cultured with nonfluorescent B6 BM fillers with optimized levels of FL
and M-CSF. After 7 days, cultures containing detectable GFP+ cells were stained and analyzed by flow cytometry.
(A) Progeny of the single progenitors were identified as GFP+.
(B–D) Examples of clones derived from single LSK cells. Clones were observed that contained (B) both macrophages and DCs, including pDCs, CD1bhi, and
CD11blo cDCs, (C) macrophages only, and (D) DCs only.
(E) The linM-CSFR+CD16/32hi MDP-enriched fraction was isolated from UBC-GFP BM.
(F) An example of a typical resulting clone from (E).
(G) Typical analysis of the progeny of BM fillers from clonal assays, showing production of macrophages, pDCs, and CD11bhi and CD11blo cDCs.
Where appropriate, data are shown on a biexponential display; a faint line indicates a change in the axis scale.
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Table 3. Frequency of BM Precursors Forming Clones Containing Both Macrophages and DCs
BM Population Isolated Subpopulation Tested Clonal Frequency (%)
Macrophage + DC Clones
(% of Total Clones)
Macrophage + DC Clones
(% of Total Cells)
Lin c-kit+sca-1+ (LSK) 10.5 ± 1.5 81.9 ± 6.9 8.5 ± 0.5
LinM-CSFR+ CD16/32hi (MDP) 1.9 ± 1.9 0 0
CD16/32int 0 – 0
CD16/32lo 6.3 ± 0.8 53.0 ± 9.7 3.2 ± 0.6
LinM-CSFR+ CD16/32lo c-kithisca-1 3.6 ± 0.5 79.5 ± 12.9 2.9 ± 0.9
c-kitintsca-1 0.5 ± 0.5 0 0
flt3+ 8.5 ± 0.5 41.7 ± 8.4 3.5 ± 0.5
flt3 4.0 ± 0.6 0 0
Linc-kithiCX3CR1
+ (MDP) – 10.6 ± 5.1 3.2 ± 2.0 0.4 ± 0.2
Single precursor cells marked either by constitutive GFP expression (lin, linM-CSFR+, and linM-CSFR+ CD16/32lo subsets) or by expression of the
CD45.1 isoform (MDPs) were sorted into cultures of BM filler cells with FL andM-CSF. The percentage of these progenitor populations that gave rise to
clones (defined as >5 detectable GFP+ or >10 CD45.1+CD45.2 progeny) was determined and termed clonal frequency. On staining and analysis,
the percentage of these clones containing both macrophages (CD11bhiF4/80+) and DCs (CD11chiCD11b+ cDCs or CD11chiCD11b cDCs or
CD11c+BST-2+ pDCs) was determined. These were termed ‘‘macrophage + DC clones;’’ clones containing solely macrophages or solely DCs
were not included in this group. Results are given as means ± standard error of two to eight experiments.
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Reconsideration of MDP as a Stage in DC Developmentcould potentially exist within other BM fractions. Because
M-CSF is the driving cytokine for macrophage development
(Stanley et al., 1983), we limited our search to the linM-CSFR+
BM fraction, which included the original MDP fraction but
excluded early multipotent progenitors, which have little or no
expression of M-CSFR (McKinstry et al., 1997). We then segre-
gated the linM-CSFR+ BM cells using a series of other markers.
The expression of CD16/32 has been linked to differential
myeloid precursor potential (Akashi et al., 2000). We had found
that the linM-CSFR+CD16/32hi population did not contain
clonal macrophage and DC progenitors (Figure 3F, Table 3).
We therefore tested the CD16/32int and CD16/32lo fractions (Fig-
ure 3E) with our clonal assay (Table 3). About 50% of the CD16/
32lo single cells that responded formed clones containing both
macrophages and DCs. In contrast, no CD16/32int cells gave
rise to both macrophages and DCs. We concluded that the
linM-CSFR+CD16/32lo population contained precursor cells
with macrophage and DC potential at the clonal level.
To further characterize these putative MDPs, the above popu-
lation was subdivided by c-kit and sca-1 or separately by flt3
(Figure 4A). In limit dilution assays, the c-kithisca-1+, c-kitlosca-
1, and flt3 fractions did not give rise to both macrophages
and DCs at any cell concentration tested. However, the c-kithi
sca-1, c-kitintsca-1, and flt3+ fractions gave rise to macro-
phages and DCs (data not shown) and were tested clonally.
Only cells within the c-kithisca-1 and flt3+ subfractions pro-
duced clones containing macrophages, pDCs, and resident-
type cDCs (Table 2). Thus, within the linM-CSFR+CD16/32lo
population, the few progenitors with both macrophage and DC
potential were c-kithisca-1flt3+.
The Developmental Potential of Prospective MDPs
In Vivo
To determinewhether thisminor BMpopulation was restricted to
the macrophage and DC lineages, we reverted to an adoptive
transfer assay. This also allowed us to further fractionate
the macrophage-DC-producing populations by expression of
CX3CR1, previously considered to be a definitive marker ofMDPs (Fogg et al., 2006). We isolated the linM-CSFR+CD16/
32loc-kithisca-1flt3+ CX3CR1
+ and CX3CR1
 fractions from
CX3CR1-GFP BM (Figure 4B) and transferred them into irradi-
ated recipients. Progenitor-derived cells were identified as
CD45.1+CD45.2 (Figure 4C). Both the CX3CR1
+ and the
CX3CR1
 subfractions gave rise to both macrophages and
DCs, as expected from the culture assays. However, both frac-
tions also gave rise to granulocytes (Figures 4D and 4E). Accord-
ingly, neither subfraction could be considered to be a restricted
MDP population. This result made it likely that the macrophage
and DC clones originated from oligopotent progenitors.
Overall, despite a systematic search, we found no BM fraction
developmentally restricted to production of macrophages
together with pDCs and resident cDCs.
DISCUSSION
A common macrophage-DC precursor population in BM, termed
MDPs (Fogg et al., 2006; Liu et al., 2009; Waskow et al., 2008), is
commonly featured in consensus models of DC development.
However, the only clonal evidence forMDPs producing bothmac-
rophages and DCs was from liquid cultures driven by GM-CSF,
sometimes together with FL (Fogg et al., 2006). Using newer
markers to detect the culture equivalents of the resident CD8+
Clec9A+ cDCs and CD45RA+ pDCs, we now show that the pro-
duction of these DCs is suppressed in the presence of the high
levels of GM-CSF previously used, even when FL is present.
Others have made similar conclusions (Zhan et al., 2011). The DC
type that dominates when GM-CSF is present at these levels re-
sembles amonocyte-derivedDC, andwe suggest that thesewere
the DCs produced in the earlier clonal assays of MDP function.
The previous argument that the MDP fraction serves as an in-
termediate precursor of resident cDCs and pDCs therefore de-
pended on the adoptive transfer assays, where MDPs produced
CD8+DCs and later some pDCs.We confirm these observations.
However, adoptive transfer assays are not clonal and will give
readouts biased to those precursors able to expand extensively;
bulk liquid culture suffers from similar problems. We now findImmunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc. 111
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ulation produces not only macrophages and DCs on adoptive
transfer but also other hematopoietic cell types, particularly
granulocytes. We consider that the precursors of these granulo-
cytes are likely to be a minority of the cells within the MDP frac-
tion and might be the same precursors that produce CD8+ DCs
and pDCs on adoptive transfer. We demonstrate that CX3CR1
+
precursors are able to produce CX3CR1
 granulocyte progeny
on adoptive transfer and in culture, although it is not clear why
this was not detected in fate-mapping studies (Jung et al.,
2000). The presence of granulocyte precursors was confirmed
in clonal agar colony assays that reflect precursors with suffi-
cient expansion potential to form visible colonies; these were
too frequent to be the result of contamination with early oligopo-
tent precursors. There are several reasons why the production of
these other lineages might have been missed in earlier adoptive
transfer experiments. In one study that used the broadM-CSFR+
definition of MDPs (Waskow et al., 2008), lymphocyte formation
was not assessed and the time point for analysis may have been
too late to observe the granulocyte formation expected from the
overlap with GMPs. In the original MDP study (Fogg et al., 2006),
the selection of light-density progeny, to remove dead cells and
erythrocytes, probably led to the loss of dense granulocytes. It is
hard to exclude the possibility that small differences in isolation
procedures explain the differing findings, but we can at least
conclude that the published procedures for MDP isolation do
not reliably produce a progenitor fraction restricted to macro-
phage and DC production.
In view of these limitations of both adoptive transfer and bulk
liquid culture, our limit dilution estimates of the frequency of pre-
cursors are particularly important. The precursors so detected
included those with a lower expansion potential than required
for adoptive transfer or colony assay. The limit dilution assays re-
vealed a high frequency of macrophage precursors in the MDP
fraction. However, the frequency of DC precursors responsive
to FL, the key cytokine for production of resident-type cDCs
and pDCs, was very low. These DC types were produced from
the BM filler cells within the same cultures, indicating that the
environment was supportive of their production. Because the
frequency of DC precursors overall was low in the MDP fraction,
the frequency of any common macrophage and DC precursors
must also have been low.
The presence in the MDP fraction of some precursors with
granulocyte potential did not eliminate the possibility that this
fraction nevertheless contained some true MDPs able to
generate resident cDCs and pDCs as well as macrophages,
and restricted to these lineages. The final test for a common
macrophage-DC progenitor required a clonal assay capable of
detecting progeny macrophages and DCs of the type presentFigure 4. Identification and Adoptive Transfer Progeny of Precursors w
(A) LinM-CSFR+CD16/32lo cells were isolated as in Figure 3E and subdivided b
(B) The linM-CSFR+CD16/32loc-kithisca-1flt3+ population was further divided
(C) Progenitor-derived cells were identified as CD45.1+CD45.2 and host-derive
(D and E) Progeny of (D) the CX3CR1
+ fraction or (E) the CX3CR1
 fraction we
CD11bhiF4/80+ macrophages and CD11bhiF4/80 monocytes, CD11c+ CD8+ an
based on the staining of populations derived from the host BM cotransferred wit
Representative plots from two to four experiments are shown.Where appropriate,
axis scale.in spleen. This was not available when the original MDP studies
were performed, but we have now devised such an assay. The
joint macrophage and DC potential was verified using early he-
matopoietic precursors, and maintenance of the correct culture
conditions was verified by the production in the same cultures of
these DCs from the BM filler cells. Importantly, upon analysis of
MDP fractions, including MDPs isolated as originally described
(Fogg et al., 2006), we found that many macrophage-restricted
clones were produced but very few common macrophage and
DC clones, consistent with the low DC precursor frequency
seen in limit dilution assays.
Our findings on theMDP fraction have practical implications in
the study of the factors involved in DC development. We revis-
ited the conclusion (Waskow et al., 2008) that FL plays no role
in the early stages of DC development. In contrast to MDPs,
CDPs, a major intermediate on the route to spleen cDCs, are
drastically reduced in FL-deficient mice. Accordingly we
conclude, in agreement with another study (Kingston et al.,
2009), that FL plays a major role in the early development of
DCs in BM, as well as in the peripheral expansion of DCs.
Our search for a common precursor restricted to production of
macrophages and resident cDCs and pDCs in all BM fractions
suggests that if such a precursor state exists, it is too infrequent
and too transient to be considered a major intermediate. This
conclusion is in agreement with a recent ‘‘barcoding’’ approach
to tracking the in vivo progeny of individual precursors from a
multipotent precursor population (Naik et al., 2013). Whenever
a population gave rise to both DCs and monocytes clonally, it
also gave rise to granulocytes upon adoptive transfer. In the light
of this and of our new clonal data, we propose MDPs be no
longer considered a key intermediate on the route to FL-depen-
dent lymphoid-tissue-resident cDCs or to pDCs.
EXPERIMENTAL PROCEDURES
Mice
Mice were 6–12 weeks of age. Unless otherwise indicated, experiments were
performed using C57BL/6J Wehi (CD45.2) mice. For clonal assays, GFP+ cells
were isolated from C57BL/6J-TG(UBC-GFP)30Scha/J mice. C57BL/6 Pep3b
(CD45.1) mice were used as donors in adoptive transfer assays. B6.129P-
CX3CR1
tm1Litt/J (CX3CR1-GFP) mice (Jung et al., 2000), also CD45.1, were
used where indicated. Mice were bred under specific-pathogen-free condi-
tions at the Walter and Eliza Hall Institute; breeding and procedures were
approved by the Animal Ethics Committee, WEHI. For analysis of precursors
in FL-deficient mice, BM was extracted from C57BL/6-flt3Ltm1Imx (FL/)
mice from the University of Western Australia Animal Care Facility under the
guidelines of the UWA Animal Ethics Office.
Monoclonal Antibodies
Unless otherwise stated, antibodies were generated from hybridoma cultures,
then concentrated, purified, and conjugated in house. The mAb hybridomaith Both Macrophage and DC Potential
y expression of c-kit and sca-1 or flt3.
into CX3CR1
+ and CX3CR1
 fractions.
d cells as CD45.1CD45.2+.
re analyzed 7 days after transfer into irradiated recipients. Progeny included
d CD8 cDCs, and Ly6G+ granulocytes. Gating of each cell type was defined
h the putative MDPs.
data are shown on a biexponential display; a faint line indicates a change in the
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(1D3) CD45R (RA36B2), CD11b (M1/70), TER119 (TER119), Ly6G (1A8),
CD45.1 (A20.1), CD45.2 (S450-15.2), CD11c (N418), F4/80 (F4/80), CD34
(RAM34), sca-1 (E13 161-7), c-kit (ACK2), flt3 (A2F10.1), CD16/32 (2.4G2),
and M-CSFR (AFS98). Purified mAbs were conjugated when required to one
of the following (from Molecular Probes): biotin, Alexa Fluor 594 (Alexa594),
Alexa Fluor 633 (Alexa633), Alexa Fluor 680 (Alexa680), phycoerythrin-cyanine
7 (PECy7), fluorescein-5-isothiocyanate (FITC), peridinin chlorophyll protein
cyanine 5.5 (PerCP-Cy5.5) (Innova Biosciences), or phycoerythrin (PE) or allo-
phycocyanin (APC) (Prozyme). Commercially produced mAb conjugates used
were A2F10 (flt3)-PE, CD49b (DX5), RAM34, and (CD34)-biotin (BD Biosci-
ences). mAb were titrated on spleen or lymph node cells or purified DCs to
determine optimal staining concentration for detection by flow cytometry.
Cytokines
ThecytokinesusedwerehumanM-CSF (R&DSystems), FL,GM-CSF, IL-3,SCF
(purified in house), and EPO (Janssen-Cilag) at the concentrations indicated.
BM Progenitor Enrichment
Erythrocytes, deadcells, andverydensecellswereeliminated fromBMcell sus-
pensions by centrifugation in Nycodenz (Nycomed Pharma) medium (1.086
g/cm3, 4C, mouse osmolarity). Remaining cells were coated with mAb against
the lineage antigens CD2, CD3, CD8, CD19, CD45R, CD11b, TER119, and
Ly6G. Cells were then incubated with polyclonal sheep anti-rat IgG magnetic
biomag beads (QIAGEN) at a ratio of eight beads/cell. Beads were removed
with amagnet (Dynal), and the unbound cells were stained for sorting precursor
fractions as indicated in text. Nonspecific antibody binding was blocked by in-
cubation with polyclonal rat Ig and, if CD16/32 was not used for sorting, with
anti-CD16/32, prior to staining for cell surface markers. Absence of lineage-
marker-bearing cells was verified in each case by staining with anti-rat Ig. Pro-
pidium iodide was included in the final stains to detect and gate out dead cells.
Lineage Potential of Progenitors In Vivo
Progenitors were isolated from CX3CR1-GFP or CD45.1 BM and 53 10
4–2 3
105 cells transferred intravenously into lethally irradiated CD45.2 recipients.
Donor-derived cells in the spleen and BM were identified as CD45.1+CD45.2
at 7 and 14 days after transfer and their lineage determined by flow cytometry
as indicated in the text.
Colony Assays
Cells were cultured as previously described (Metcalf et al., 2002) in DMEM
(Hyclone) at 20% fetal calf serum and 0.3% w/v agar, with GM-CSF (10
ng/ml); M-CSF (10 ng/ml); or IL-3 (10 ng/ml), SCF (100 ng/ml), and EPO (21
U/ml). Cells were cultured for 7 days, then fixed for 4 hr with 2.5% glutaralde-
hyde and stained with acetylcholinesterase, Luxol fast blue, and hematoxylin.
Limit Dilution Assays
Progenitor populations were isolated as described from CX3CR1-GFP CD45.1
BM and cultured at concentrations from 1 cell to 1.5 3 104 cells with 3 3 105
CD45.2 BM filler cells for 7 days at 37.5C with 10% CO2 in air with either FL
(200 ng/ml), M-CSF (25 ng/ml), or both FL andM-CSF at these concentrations.
Cultures were then analyzed by flow cytometry for the presence of macro-
phages and DCswithin the CD45.1+CD45.2 progenitor-derived cells. The fre-
quency of macrophage or DC progenitors was calculated using Extreme
Limiting Dilution Analysis software (Hu and Smyth, 2009).
Clonal Assays for Macrophage and DC Potential
Candidate progenitors were sorted from UBC-GFP or CD45.1+CX3CR1-GFP
BM as indicated. Single cells were deposited by a FACS DiVA, BD Influx, or
BD Aria into each well of a 96-well U-bottom tissue culture plate containing
0.3 3 106 filler cells in 0.2 ml modified RPMI-1640 medium with 10% fetal
bovine serum with FL (200 ng/ml) and M-CSF (25 ng/ml). Cells were cultured
at 37.5Cwith 10%CO2 in air for 7 days. Eachwell fromUBC-GFPBMprogen-
itor assays was screened by illumination under ultraviolet light for the presence
of GFP+ progeny. Wells with more than five GFP+ cells were harvested with
medium containing EDTA. If CX3CR1-GFP BM was used, each well was har-
vested. The entire contents of the wells were stained then analyzed by flow
cytometry for the presence of progenitor-derived macrophages and DCs.114 Immunity 41, 104–115, July 17, 2014 ª2014 Elsevier Inc.Flow Cytometry Instruments and Software
Analytical and preparative flow cytometry was carried out on FACS DiVa, LSR,
LSR II, LSR Fortessa, ARIA, Influx (Becton Dickinson), or Mo-Flo (Cytomation)
instruments. Analysis of data was performed using WEASEL software
(F. Battye, The Walter and Eliza Hall Institute) or Flowjo (TreeStar).
Statistical Analysis
Statistical analysis was performed using the program GraphPad Prism
(GraphPad) or Extreme Limit Dilution Analysis (ELDA) software (Hu and Smyth,
2009).
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